Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4104865
Max Phase: Preclinical
Molecular Formula: C68H119N23O8
Molecular Weight: 1386.85
Molecule Type: Small molecule
Associated Items:
ID: ALA4104865
Max Phase: Preclinical
Molecular Formula: C68H119N23O8
Molecular Weight: 1386.85
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)NC(=O)N[C@H](CNC(=N)N[C@@H](CCCCN)CCC(=O)N[C@H](CNC(=O)N[C@H](CNC(=O)N[C@@H](CCCCN)CNC(=O)N[C@H](CNC(=O)N[C@@H](CCCCN)CNC(=O)N[C@H](CNC(N)=O)C(C)C)Cc1c[nH]c2ccccc12)C(C)C)Cc1c[nH]c2ccccc12)C(C)C
Standard InChI: InChI=1S/C68H119N23O8/c1-42(2)57(91-68(99)83-45(7)8)39-76-61(72)85-48(19-13-16-28-69)26-27-60(92)84-51(31-46-33-74-55-24-11-9-22-53(46)55)37-81-67(98)90-59(44(5)6)41-82-65(96)87-49(20-14-17-29-70)35-78-64(95)88-52(32-47-34-75-56-25-12-10-23-54(47)56)38-80-63(94)86-50(21-15-18-30-71)36-79-66(97)89-58(43(3)4)40-77-62(73)93/h9-12,22-25,33-34,42-45,48-52,57-59,74-75H,13-21,26-32,35-41,69-71H2,1-8H3,(H,84,92)(H3,72,76,85)(H3,73,77,93)(H2,78,88,95)(H2,79,89,97)(H2,80,86,94)(H2,81,90,98)(H2,82,87,96)(H2,83,91,99)/t48-,49-,50-,51-,52-,57+,58+,59+/m0/s1
Standard InChI Key: UOOHAJUPGKYXBN-JZOXCTCKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1386.85 | Molecular Weight (Monoisotopic): 1385.9612 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Antunes S, Corre JP, Mikaty G, Douat C, Goossens PL, Guichard G.. (2017) Effect of replacing main-chain ureas with thiourea and guanidinium surrogates on the bactericidal activity of membrane active oligourea foldamers., 25 (16): [PMID:28687228] [10.1016/j.bmc.2017.04.040] |
Source(1):